AFFINISOL: Pharmabiz.com  
 
 
 
       
  Editorial
 PRESCRIPTION AUDIT & MEDICAL COSTS   
 Wednesday, February 25, 2015 
 Steeply rising medical costs among the millions of middle class and poor people of this country in the absence of inadequate insurance cover are pushing many of them into indebtedness and poverty. 
  Past Editorial...  
TODAY'S NEWS
13:00  [IST]Gilead reports positive results from preclinical study of investigational TLR7 agonist in SIV-infected, virally suppressed monkeys
12:00  [IST]US FDA accepts for review Teva's NDA for hydrocodone bitartrate ER tablets with proprietary abuse deterrence technology
11:00  [IST]Amgen phase 3 study comparing AMG 416 with cinacalcet in patients with SHPT receiving hemodialysis meets primary endpoint
10:00  [IST]US FDA approves Sanofi's once-daily basal insulin Toujeo
09:00  [IST]Bonesupport gets Indian regulatory nod to market injectable antibiotic eluting bone substitute, Cerament
more news >>
TOP NEWS
08:00  [IST]DRL gets final hearing from State FDA minister in a case related to violation of D&C Act
08:00  [IST]NPPA to discuss identification marks for drugs under ceiling price with trade, BDCDA wants red color on packs
08:00  [IST]BIRAC invites proposals from biotech companies under BIPP scheme
08:00  [IST]CDSCO Ahmedabad becomes first ISO certified zonal regulatory office in India
08:00  [IST]IMA should challenge govt rules allowing Ayush professionals practising allopathy: Dr M C Gupta
08:00  [IST]DCGI debars Arion, Kivi Labs for 5 years for submitting fabricated data for obtaining various approvals
more news >>
YESTERDAY'S NEWS
18:00  [IST]Neos completes $20.6 mn financing for advance its late-stage ADHD product pipeline
17:00  [IST]Cyberonics' Vitaria System receives CE Mark approval to treat chronic heart failure
16:00  [IST]Cerilliant introduces Certified Spiking Solutions of tryptamines
15:00  [IST]Cosmo, Santarus sue Actavis on generic Uceris patent
14:45  [IST]Metropolis Healthcare slashes price for Swine Flu testing to Rs.4000
14:00  [IST]Celltrion introduces biosimilar mAb, Remsima in 12 EU markets
more news >>
INTERVIEW  
Life sciences an important industry for Information Technology companies
Ramesh J. Chougule, Associate Vice President, Life Sciences and Services, Infosys, tells Nandita Vijay
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the union health ministry's recent decision to ban polyethylene terephthalate (PET) bottles as primary packaging material in pharmaceutical industry justified?
 
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
Copyright © 2015 Saffron Media Pvt. Ltd |